Clinical Effectiveness and Cost Effectiveness of Tailoring Chronic Hepatitis C Treatment with Peginterferon Alpha-2b Plus Ribavirin to HCV Genotype and Early Viral Response : A Decision Analysis Based on German Guidelines
In: PharmacoEconomics, Vol. 27 (2009), No. 4, pp. 341 - 354
2009article/chapter in journal
EconomicsMedicineFaculty of Business Administration and Economics » Business Administration » Health Care Management
Related: 1 publication(s)
Title in English:
Clinical Effectiveness and Cost Effectiveness of Tailoring Chronic Hepatitis C Treatment with Peginterferon Alpha-2b Plus Ribavirin to HCV Genotype and Early Viral Response : A Decision Analysis Based on German Guidelines
Author:
Siebert, Uwe
- Other
- corresponding author
- GND
- 110790677
- LSF ID
- 5214
- ORCID
- 0000-0001-9653-168X
- Other
- connected with university
Year of publication:
2009
Language of text:
English